4//SEC Filing
Gilmartin Geoffrey S. 4
Accession 0001209191-19-007570
CIK 0001445283other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:59 PM ET
Size
9.5 KB
Accession
0001209191-19-007570
Insider Transaction Report
Form 4
Gilmartin Greffrey S.
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2019-02-01+24,100→ 24,100 total - Sale
Common Stock
2019-02-04$2.99/sh−9,189$27,480→ 14,911 total - Exercise/Conversion
Restricted Stock Units
2019-02-01−24,100→ 0 total→ Common Stock (24,100 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and were made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.96 to $3.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The restricted stock units vested in full on February 1, 2019.
Documents
Issuer
PROTEOSTASIS THERAPEUTICS, INC.
CIK 0001445283
Entity typeother
Related Parties
1- filerCIK 0001688268
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:59 PM ET
- Size
- 9.5 KB